Sujitha Thottam
Adult Health · Jamaica, NYNPI 1487956140
Payments from drug & device makers
Across 302 payments — averaging $29.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Abbott$1K
- Amgen$829
- Corcept Therapeutics$811
- AstraZeneca$595
- Lilly USA, LLC$578
- plus $4K from 28 others
What the payments were for
- Food & beverage$8,960100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $1,336 |
| Abbott | 24 | $1,079 |
| Amgen(2 entities) | 29 | $829 |
| Corcept Therapeutics | 26 | $811 |
| AstraZeneca(2 entities) | 19 | $595 |
| Lilly USA, LLC | 23 | $578 |
| Amneal Pharmaceuticals LLC | 23 | $486 |
| Xeris Pharmaceuticals, Inc. | 22 | $352 |
| Dexcom, Inc. | 6 | $344 |
| Madrigal Pharmaceuticals | 2 | $275 |
| Mannkind Corporation | 7 | $272 |
| Intuity Medical Inc | 3 | $231 |
| Vifor Pharma, Inc. | 6 | $228 |
| Sanofi-aventis U.S. LLC | 11 | $200 |
| Novartis | 10 | $185 |
| Amryt Pharma Holdings Ltd | 4 | $176 |
| Johnson & Johnson | 7 | $167 |
| Pfizer | 8 | $153 |
| Radius Health, Inc. | 6 | $144 |
| Chiesi USA, Inc. | 4 | $85 |
| Zealand Pharma US, Inc. | 3 | $78 |
| Janssen Scientific Affairs, LLC | 2 | $51 |
| Merck | 2 | $46 |
| Insulet Corporation | 2 | $33 |
| Tandem Diabetes Care, Inc. | 2 | $32 |
| Ionis Pharmaceuticals, Inc. | 1 | $28 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Althera Pharmaceuticals LLC | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Lifescan, Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$462
- FREESTYLE LIBRE 3$421
- REZDIFFRA$275
- EVENITY$250
- DEXCOM G6 TRANSMITTER$244
- FreeStyle Libre 2$228
- Strensiq$132
- FARXIGA$125
- Veltassa$125
- AFREZZA$124
- Korlym$122
- Pogo Automatic Blood Glucose Monitoring System$113
- MYCAPSSA$112
How this compares
$8,960 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 97 | $186,170 |
| JardianceEmpagliflozin | 108 | $110,600 |
| FarxigaDapagliflozin Propanediol | 51 | $57,803 |
| JanumetSitagliptin Phos/Metformin Hcl | 43 | $55,869 |
| ProliaDenosumab | 23 | $36,087 |
| Tresiba Flextouch U-200Insulin Degludec | 40 | $33,015 |
| TrulicityDulaglutide | 26 | $31,106 |
| Tresiba Flextouch U-100Insulin Degludec | 25 | $21,653 |
| JanuviaSitagliptin Phosphate | 17 | $17,077 |
| Novolog FlexpenInsulin Aspart | 70 | $12,846 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 33 | $10,785 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 59 | $8,737 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 57 | $5,311 |
| Repaglinide | 58 | $2,120 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 34 | $1,820 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,336 | $186,17097 claims |
| MerckJanumet, Januvia | $46 | $72,94660 claims |
| AstraZenecaFarxiga | $595 | $57,80351 claims |
| AmgenProlia | $829 | $36,08723 claims |
| Lilly USA, LLCTrulicity | $578 | $31,10626 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $486 | $1,06157 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in Jamaica
- Nermala PersaudJamaica$28K
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.